Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has shifted from a diabetes-only medication to a recognized tool for chronic weight loss in adults without diabetes who meet specific eligibility criteria. The FDA approved semaglutide (brand name Wegovy) for weight management in 2021, expanding access beyond its original diabetes indication and opening treatment options for millions of Americans struggling with weight.

Who Qualifies for Semaglutide Weight Loss Therapy

Semaglutide eligibility for weight loss does not require a diabetes diagnosis. Adults qualify if they have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, high cholesterol, or sleep apnea. Medical evaluation by a licensed clinician confirms individual suitability and rules out contraindications.

Pregnancy, breastfeeding, and personal or family history of medullary thyroid cancer exclude candidates from semaglutide therapy. A comprehensive health history review identifies any conditions that would make treatment unsafe. PlexusDx clinicians perform this screening during the initial consultation to ensure patient safety and treatment appropriateness.

How Semaglutide Works for Weight Management

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that reduces hunger signals in the brain and slows gastric emptying. These dual mechanisms lower appetite and increase feelings of fullness after smaller meal portions, leading to sustained calorie reduction without the restrictive willpower typically required by diet alone. Clinical trials demonstrate that patients on semaglutide lose an average of 10-15% of baseline body weight over 68 weeks.

The medication works on pathways independent of diabetes status, making it effective for weight loss in people without blood sugar disorders. Genetic variations in GLP-1 receptor sensitivity influence individual response rates, which is why PlexusDx offers the Precision Peptide Genetic Test to identify peptide-pathway predispositions and optimize therapy selection.

Semaglutide Injection vs. Oral Semaglutide: What's the Difference

PlexusDx offers two semaglutide delivery formats: weekly injections starting at $189 per month and daily oral tablets starting at $289 per month. Injectable semaglutide delivers higher bioavailability and generally produces faster, more consistent weight loss results because it bypasses digestive breakdown. The oral form provides convenience for patients who prefer daily medication routines and have needle anxiety.

Both formats are compounded by licensed 503A pharmacies and require no insurance, no membership fees, and are HSA/FSA eligible. Dose escalation follows clinical protocols that adjust therapeutic strength based on tolerance and response, but pricing remains flat at the committed tier regardless of dose level.

Getting Started with Semaglutide at PlexusDx

PlexusDx serves all 50 states and launches patients on semaglutide through a straightforward three-step process: initial medical assessment by a licensed clinician, selection of injection or oral format based on preference and clinical needs, and ongoing telehealth monitoring with dose adjustments as needed. No insurance is required, and treatment is available immediately upon approval.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I use semaglutide for weight loss if I don't have diabetes?

Yes. Semaglutide was FDA-approved specifically for chronic weight management in adults without diabetes who have a BMI of 30 or higher, or 27 or higher with weight-related health conditions. A licensed clinician must confirm your eligibility during the initial assessment.

How much weight can I expect to lose on semaglutide?

Clinical trial data shows average weight loss of 10-15% of baseline body weight over 68 weeks of semaglutide therapy. Individual results vary based on genetics, lifestyle, and medication adherence. PlexusDx Precision Peptide Genetic Testing can identify genetic predispositions that may influence your response.

How much does semaglutide cost at PlexusDx?

PlexusDx compounded semaglutide injections start at $189/mo (or $149/mo on the 6-month plan) across all commitment tiers. Your dose may need to go up during therapy titration, but your price won't. Oral semaglutide starts at $289/mo (or $249/mo on the 6-month plan). Treatment is HSA/FSA eligible and requires no insurance.

What are common side effects of semaglutide for weight loss?

Nausea, vomiting, constipation, and decreased appetite are the most frequently reported side effects, typically occurring during dose escalation and improving as your body adjusts. Serious side effects are rare but include pancreatitis and allergic reactions. PlexusDx clinicians monitor for adverse effects throughout your treatment.

How does the Precision Peptide Genetic Test improve my semaglutide therapy?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves